Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K, Yasumatsu R, Toh S, Shiratsuchi H, Yoshida T, Nishiyama K, Yoshikawa H, Nakashima T, Nakagawa T. Hashimoto K, et al. Among authors: toh s. Auris Nasus Larynx. 2016 Dec;43(6):666-71. doi: 10.1016/j.anl.2016.02.011. Epub 2016 Mar 7. Auris Nasus Larynx. 2016. PMID: 26965587
Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y. Nakano T, et al. Among authors: toh s. Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17. Hum Pathol. 2016. PMID: 26997438
Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma.
Hashimoto K, Yasumatsu R, Kuga R, Hongo T, Yamamoto H, Matsuo M, Wakasaki T, Jiromaru R, Manako T, Toh S, Masuda M, Yamauchi M, Kuratomi Y, Uryu H, Nakashima T, Tamae A, Tanaka R, Taura M, Takeuchi T, Yoshida T, Nakagawa T. Hashimoto K, et al. Among authors: toh s. Anticancer Res. 2022 Feb;42(2):981-989. doi: 10.21873/anticanres.15558. Anticancer Res. 2022. PMID: 35093898
Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study.
Nakano T, Yasumatsu R, Hashimoto K, Kuga R, Hongo T, Yamamoto H, Matsuo M, Wakasaki T, Jiromaru R, Manako T, Toh S, Masuda M, Yamauchi M, Kuratomi Y, Taura M, Takeuchi T, Nakagawa T. Nakano T, et al. Among authors: toh s. Anticancer Res. 2022 Jul;42(7):3653-3664. doi: 10.21873/anticanres.15854. Anticancer Res. 2022. PMID: 35790253
857 results